Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis

References

• BastRCJrStatus of tumor markers in ovarian cancer screeningJ Clin Oncol200321200s205s12743135
   PubMedGoogle Scholar
• PiverMSBakerTRDriscollDLLack of substantial five year disease-free survival by primary aggressive surgery and cisplatin-based chemotherapy or by salvage intraperitoneal cisplatin-based chemotherapyEur J Gynaecol Oncol1990112432502245807
   PubMedGoogle Scholar
• OzolsRRubinSThomasGRobboySJEpithelial ovarian cancerHoskinsWJPerezCAYoungRCBarakatRMarkmanMRandallMPrinciples and Practice of Gynecologic Oncology4th edPhiladelphiaLippincott Williams & Wilkins2005895989
   Google Scholar
• HellströmIRayeraftJHayden-LedbetterMThe HE4 (WFDC2) protein is a biomarker for ovarian carcinomaCancer Res2003633695370012839961
   PubMed Web of Science ®Google Scholar
• MooreRGBrownAKMillerMCThe use of multiple novel tumor biomarkers for the detection of ovarian carcinoma patients with a pelvic massGynecol Oncol200810840240818061248
   PubMed Web of Science ®Google Scholar
• HavrileskyLJWhiteheadCMRubattJMEvaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrenceGynecol Oncol200811037438218584856
   PubMed Web of Science ®Google Scholar
• DongLChangXHYeXThe values of serum human epidermis secretory protein 4 and CA125 assay in the diagnosis of ovarian malignancyZhonghua Fu Chan Ke Za Zhi200843931936 Chinese19134334
   PubMedGoogle Scholar
• MontagnanaMLippiGRuzzenenteOThe utility of serum human epididymis protein 4 (HE4) in patients with a pelvic massJ Clin Lab Anal20092333133519774626
   PubMed Web of Science ®Google Scholar
• HuhtinenKSuvitiePHiissaJSerum HE4 concentration differentiates malignant ovarian tumors from ovarian endometriotic cystsBr J Cancer20091001315131919337252
   PubMed Web of Science ®Google Scholar
• Abdel-AzeezHALabibHASharafSMRefaiANHE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic massesAsian Pac J Cancer Prev20101111111620593939
   PubMed Web of Science ®Google Scholar
• AndersenMRGoffBALoweKAUse of a symptom index, CA125, and HE4 to predict ovarian cancerGynecol Oncol201011637838319945742
   PubMed Web of Science ®Google Scholar
• ChenGDLiZGQianDYThe value of human epidermis secretory protein in the diagnosis of pelvic massesJ Pract Med20102627742776
   Google Scholar
• KeLLiuFHThe value of serum HE4 and CA125 in the diagnosis of ovarian cancerMod Med (Chic)2010108586
   Google Scholar
• LiuGRWangALLiuQCombined detection of serum CA125 and HE4 for ovarian cancer diagnosis and differential diagnosisChin J Clin Lab Sci201028119121
   Google Scholar
• MaLYanCLPiaoWHThe clinical application of serum human epidermis protein 4 in the aided diagnosis of ovarian cancerNingxia Med J20103210381039
   Google Scholar
• WangKYLengJHDengHThe value of combined detection of serum HE4 and CA125 in the diagnosis of ovarian cancerChin J Health Lab20102011391140
   Google Scholar
• XuCLYangYHWangHLThe value of serum human epidermis protein 4 epithelial in the diagnosis of ovarian cancerChin J Gynecol Obstet201026684686
   Google Scholar
• YaoYLLiuQLiXYThe application value of joint inspections of serum HE4, TPS and CA125 in the diagnosis of ovarian cancerRadiat J Immunol201023409411
   Google Scholar
• LuMDChenDZZhaoJThe expression of joint detection of HE4 and CA125 in ovarian tumors and its clinical significanceChin Matern Child Health2010536233625
   Google Scholar
• LiuYNYeXChengHYMeasurement of serum human epidermis secretory protein 4 combined with the CA125 assay in the differential diagnosis of endometriosis cyst and ovarian benign and malignant tumorsChin J Obstet Gynecol201045363366
   Google Scholar
• MontagnanaMDaneseERuzzenenteOThe ROMA (risk of ovarian malignancy algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?Clin Chem Lab Med20114952152521288178
   PubMed Web of Science ®Google Scholar
• AllardJSomersETheilRMooreRGUse of a novel biomarker HE4 for monitoring patients with epithelial ovarian cancerJ Clin Oncol2008265535
   Web of Science ®Google Scholar
• Van GorpTCadronIDespierreEHE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the risk of ovarian malignancy algorithmBr J Cancer201110486387021304524
   PubMed Web of Science ®Google Scholar
• MooreRGMillerMCDisilvestroPEvaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic massObstet Gynecol201111828028821775843
   PubMed Web of Science ®Google Scholar
• KimYMWhangDHParkJEvaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean populationClin Chem Lab Med20114952753421320028
   PubMed Web of Science ®Google Scholar
• JacobFMeierMCaduffRNo benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical settingGynecol Oncol201112148749121420727
   PubMed Web of Science ®Google Scholar
• HolcombKVuceticZMillerMCKnappRCHuman epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal womenAm J Obstet Gynecol2011205358. e1e621722869
   PubMed Web of Science ®Google Scholar
• EscuderoJMAugeJMFilellaXTorneAPahisaJMolinaRComparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseasesClin Chem2011571534154421933899
   PubMed Web of Science ®Google Scholar
• ChangXYeXDongLHuman epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinomaInt J Gynecol Cancer20112185285821633297
   PubMed Web of Science ®Google Scholar
• BandieraERomaniCSpecchiaCSerum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer managementCancer Epidemiol Biomarkers Prev2011202496250622028406
   PubMed Web of Science ®Google Scholar
• ZhengHGaoYSerum HE4 as a useful biomarker in discriminating ovarian cancer from benign pelvic diseaseInt J Gynecol Cancer2012221000100522426406
   PubMed Web of Science ®Google Scholar
• KarlsenMASandhuNHøgdallCEvaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic massGynecol Oncol201212737938322835718
   PubMed Web of Science ®Google Scholar
• KadijaSStefanovicAJeremicKThe utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosisInt J Gynecol Cancer20122223824422214964
   PubMed Web of Science ®Google Scholar
• HamedEOAhmedHSedeekOBMohammedAMAbd-AllaAAAbdel GhaffarHMSignificance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment responseDiagn Pathol201381123343214
   PubMed Web of Science ®Google Scholar
• AzzamAZHashadDIKamelNAEvaluation of HE4 as an extrabio-marker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?Arch Gynecol Obstet Epub1302013
   Web of Science ®Google Scholar
• YuSYangHJXieSQBaoYXDiagnostic value of HE4 for ovarian cancer: a meta-analysisClin Chem Lab Med2012501439144622868811
   PubMed Web of Science ®Google Scholar
• LiFTieRChangKDoes risk for ovarian malignancy algorithm excel human epididymis protein 4 and ca125 in predicting epithelial ovarian cancer: a meta-analysisBMC Cancer20121225822712526
   PubMed Web of Science ®Google Scholar
• WuLDaiZYQianYHShiYLiuFJYangCDiagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysisInt J Gynecol Cancer2012221106111222854652
   PubMed Web of Science ®Google Scholar
• SandriMTBottariFFranchiDComparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcomeGynecol Oncol201312823323823200911
   PubMed Web of Science ®Google Scholar